Effect of Oxygenated Mouthwash and Mouth Foam

Sponsor
King's College London (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT06079307
Collaborator
King Saud University (Other)
60
1
3
3
19.9

Study Details

Study Description

Brief Summary

The Aim of this independent, parallel, twelve-week clinical study is to assess the efficacy of a commercially available oxygenated mouth rinse and mouth foam on both plaque level and gingival status in addition to assessing the oral health related quality of life.

Condition or Disease Intervention/Treatment Phase
  • Other: Oxygenated Mouthwash
  • Other: Oxygenated mouth foam
N/A

Detailed Description

Participants in all groups will be examined for gingival inflammation and plaque accumulation. The difference between three trial arms lies in the product used (control, oxygenated mouth wash, oxygenated mouth foam). A comparison against no intervention was disregarded due to ethical concerns (children only examined without informing them about their oral problems). After examination at baseline participants will be assigned to one arm of intervention. All participants will be provided an oral health education and gingival scaling to remove any underlining predisposing factor for gingival inflammation as well as fluoridated toothpaste and a toothbrush. Participants within intervention arms will also be provided the product package and informed how to use it (oxygenated mouth wash, oxygenated mouth foam).

All three arms will be followed after (1week, 2 weeks, 4 weeks, 8 weeks and 12 weeks) from baseline examination.

  1. Control group Won't receive an oxygenated mouthwash nor oxygenated mouth foam (20 participants) 2. Intervention Group A: 20 participants - 2 oxygenated mouthwash bottle per individual for 3 months (40 bottles in total).

  2. Intervention Group B: Oxygenated mouth foam/ day 20 participants- 2 oxygenated mouth foam bottle per individual for 3 months (40 bottles in total).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
3 parallel arms running for 12 months and six-points data collection (examination - plaque index and gingival index)3 parallel arms running for 12 months and six-points data collection (examination - plaque index and gingival index)
Masking:
Single (Outcomes Assessor)
Masking Description:
due to ethical consideration participants cannot be blinded nor examiners as they will be providing oral hygiene instructions and information relative to using the mouth rinse and the mouth foam. everyone handling the data after examination will be blinded, they will be dealing with data obtained after identifying an identification code to each participant.
Primary Purpose:
Other
Official Title:
Effect of Oxygenated Mouthwash and Mouth Foam on Oral Health and Quality of Life
Actual Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

Won't receive an oxygenated mouthwash nor oxygenated mouth foam yet will be provided a fluoridated toothpaste and a toothbrush (20 participants)

Experimental: Oxygenated mouthwash Group

Provided with oxygenated mouthwash bottle 2 per individual for 3 months (40 bottles in total). -20 participants -

Other: Oxygenated Mouthwash
Will be comparing the impact of using oxygenated mouthwash with other groups.

Experimental: Oxygenated mouth foam Group

Provided with oxygenated mouth foam/ day- 20 participants- 2 oxygenated mouth foam bottle per individual for 3 months (40 bottles in total).

Other: Oxygenated mouth foam
will be comparing the impact of using oxygenated foam to other groups.

Outcome Measures

Primary Outcome Measures

  1. Gingival index [baseline]

    Gingival index has been used to clinically characterize the degree of gingival inflammation. were the scale range 0-3. zero indicating the best results and 3 as sever gingivitis.

  2. Gingival index [+1 week from baseline]

    Gingival index has been used to clinically characterize the degree of gingival inflammation. were the scale range 0-3. zero indicating the best results and 3 as sever gingivitis.

  3. Gingival index [+2 weeks from baseline]

    Gingival index has been used to clinically characterize the degree of gingival inflammation. were the scale range 0-3. zero indicating the best results and 3 as sever gingivitis.

  4. Gingival index [+4 weeks from baseline]

    Gingival index has been used to clinically characterize the degree of gingival inflammation. were the scale range 0-3. zero indicating the best results and 3 as sever gingivitis.

  5. Gingival index [+8 weeks from baseline]

    Gingival index has been used to clinically characterize the degree of gingival inflammation. were the scale range 0-3. zero indicating the best results and 3 as sever gingivitis.

  6. Gingival index [+12 weeks from baseline]

    Gingival index has been used to clinically characterize the degree of gingival inflammation. were the scale range 0-3. zero indicating the best results and 3 as sever gingivitis.

  7. Plaque index [baseline]

    Oral hygiene may be assessed via a plaque index also plaque is a predisposing factor for gingival inflammation.

  8. Plaque index [+1 week from baseline]

    Oral hygiene may be assessed via a plaque index also plaque is a predisposing factor for gingival inflammation

  9. Plaque index [+2 weeks from baseline]

    Oral hygiene may be assessed via a plaque index also plaque is a predisposing factor for gingival inflammation

  10. Plaque index [+4 weeks from baseline]

    Oral hygiene may be assessed via a plaque index also plaque is a predisposing factor for gingival inflammation

  11. Plaque index [+8 weeks from baseline]

    Oral hygiene may be assessed via a plaque index also plaque is a predisposing factor for gingival inflammation

  12. Plaque index [+12 weeks from baseline]

    Oral hygiene may be assessed via a plaque index also plaque is a predisposing factor for gingival inflammation

Secondary Outcome Measures

  1. Gum Health Experience Questionnaire (GHEQ) [Baseline]

    The questions are designed to assess the impact that gum-related symptoms may have on your everyday life. (Assessed through Likert scale were the 5 is the highest score and 1 is the lowest score)

  2. Gum Health Experience Questionnaire (GHEQ) [+12 weeks from baseline]

    The questions are designed to assess the impact that gum-related symptoms may have on your everyday life. (Assessed through Likert scale were the 5 is the highest score and 1 is the lowest score)

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Students and employees at College of applied Medical science over 19 years old

  • Both Saudis and non-Saudis.

  • Students and employees consenting to participate.

Exclusion Criteria:
  • Intern students or students in their 1st year.

  • Students and employees with medically compromised condition (including congenital heart disease, hematological condition, immune deficiency condition and end stage renal disease or those with organ transplant within the previous 5 year.

  • Students and employees not consenting to participate.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Haya Mahmmod Alayadi Riyadh Saudi Arabia 4312

Sponsors and Collaborators

  • King's College London
  • King Saud University

Investigators

  • Principal Investigator: Haya M Alayadi, PhD, King Saud University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
King's College London
ClinicalTrials.gov Identifier:
NCT06079307
Other Study ID Numbers:
  • E-23- KSU-1001
First Posted:
Oct 12, 2023
Last Update Posted:
Oct 18, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 18, 2023